Lunai Bioworks (LNAI) Revenue (2013 - 2026)
Lunai Bioworks (LNAI) posted Revenue of $20942.0 for Q1 2026, up 8482.79% on a QoQ basis from $244.0 in Q2 2016.
Powered by 
Analysis
Lunai Bioworks (LNAI) Revenue (2013 - 2026) Analysis & Trends
Lunai Bioworks has reported Revenue for 3 years, with the latest figure at $20942.0 in Q1 2026.
- On a quarterly basis, Revenue changed N/A year-over-year to $20942.0 in Q1 2026; TTM through Mar 2026 was $85227.0, a N/A change from a year earlier, with the FY2016 full-year figure at $42769.0, changed N/A from the prior year.
- Revenue was $20942.0 for Q1 2026 at Lunai Bioworks, up from $244.0 in the prior quarter.
- The five-year high for Revenue was $20942.0 in Q1 2026, with the low at $20942.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 490,000.00 |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 77.46 Mn |
| 10 | Lunai Bioworks | 8.19 Mn | 5.03 Mn | 20,942.00 | 20,942.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 20,942.00 |
| Jun 30, 2016 | 244.00 |
| Sep 30, 2013 | 32,483.00 |
| Jun 30, 2013 | 31,558.00 |
| Mar 31, 2013 | 31,558.00 |